Angiosarcoma.
Identifieur interne : 003B66 ( Ncbi/Curation ); précédent : 003B65; suivant : 003B67Angiosarcoma.
Auteurs : Robin J. Young [Royaume-Uni] ; Nicola J. Brown ; Malcolm W. Reed ; David Hughes ; Penella J. WollSource :
- The Lancet. Oncology [ 1474-5488 ] ; 2010.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Hémangiosarcome.
- diagnostic : Hémangiosarcome.
- génétique : Hémangiosarcome.
- étiologie : Hémangiosarcome.
- Diagnostic différentiel, Facteurs de risque, Femelle, Humains, Hémangiosarcome, Mâle, Résultat thérapeutique, Stade de la tumeur, Valeur prédictive des tests.
English descriptors
- KwdEn :
- MESH :
- diagnosis : Hemangiosarcoma.
- etiology : Hemangiosarcoma.
- genetics : Hemangiosarcoma.
- pathology : Hemangiosarcoma.
- therapy : Hemangiosarcoma.
- Diagnosis, Differential, Female, Humans, Male, Neoplasm Staging, Predictive Value of Tests, Risk Factors, Treatment Outcome.
Abstract
Angiosarcomas are rare soft-tissue sarcomas of endothelial cell origin that have a poor prognosis. They can arise anywhere in the body, most commonly presenting as cutaneous disease in elderly white men, involving the head and neck and particularly the scalp. They can be caused by therapeutic radiation or chronic lymphoedema and hence secondary breast angiosarcomas are an important subgroup. Recent work has sought to establish the molecular biology of angiosarcomas and identify specific targets for treatment. Interest is now focused on trials of vascular-targeted drugs, which are showing promise in the control of angiosarcomas. In this review we discuss angiosarcoma and its current management, with a focus on clinical trials investigating the treatment of advanced disease.
DOI: 10.1016/S1470-2045(10)70023-1
PubMed: 20537949
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002A41
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002A41
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002A41
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003B66
Links to Exploration step
pubmed:20537949Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Angiosarcoma.</title>
<author><name sortKey="Young, Robin J" sort="Young, Robin J" uniqKey="Young R" first="Robin J" last="Young">Robin J. Young</name>
<affiliation wicri:level="1"><nlm:affiliation>Academic Unit of Surgical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK. r.j.young@shefeld.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Academic Unit of Surgical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield</wicri:regionArea>
<wicri:noRegion>Sheffield</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brown, Nicola J" sort="Brown, Nicola J" uniqKey="Brown N" first="Nicola J" last="Brown">Nicola J. Brown</name>
</author>
<author><name sortKey="Reed, Malcolm W" sort="Reed, Malcolm W" uniqKey="Reed M" first="Malcolm W" last="Reed">Malcolm W. Reed</name>
</author>
<author><name sortKey="Hughes, David" sort="Hughes, David" uniqKey="Hughes D" first="David" last="Hughes">David Hughes</name>
</author>
<author><name sortKey="Woll, Penella J" sort="Woll, Penella J" uniqKey="Woll P" first="Penella J" last="Woll">Penella J. Woll</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20537949</idno>
<idno type="pmid">20537949</idno>
<idno type="doi">10.1016/S1470-2045(10)70023-1</idno>
<idno type="wicri:Area/PubMed/Corpus">002A41</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A41</idno>
<idno type="wicri:Area/PubMed/Curation">002A41</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002A41</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A41</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A41</idno>
<idno type="wicri:Area/Ncbi/Merge">003B66</idno>
<idno type="wicri:Area/Ncbi/Curation">003B66</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Angiosarcoma.</title>
<author><name sortKey="Young, Robin J" sort="Young, Robin J" uniqKey="Young R" first="Robin J" last="Young">Robin J. Young</name>
<affiliation wicri:level="1"><nlm:affiliation>Academic Unit of Surgical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK. r.j.young@shefeld.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Academic Unit of Surgical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield</wicri:regionArea>
<wicri:noRegion>Sheffield</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brown, Nicola J" sort="Brown, Nicola J" uniqKey="Brown N" first="Nicola J" last="Brown">Nicola J. Brown</name>
</author>
<author><name sortKey="Reed, Malcolm W" sort="Reed, Malcolm W" uniqKey="Reed M" first="Malcolm W" last="Reed">Malcolm W. Reed</name>
</author>
<author><name sortKey="Hughes, David" sort="Hughes, David" uniqKey="Hughes D" first="David" last="Hughes">David Hughes</name>
</author>
<author><name sortKey="Woll, Penella J" sort="Woll, Penella J" uniqKey="Woll P" first="Penella J" last="Woll">Penella J. Woll</name>
</author>
</analytic>
<series><title level="j">The Lancet. Oncology</title>
<idno type="eISSN">1474-5488</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Female</term>
<term>Hemangiosarcoma (diagnosis)</term>
<term>Hemangiosarcoma (etiology)</term>
<term>Hemangiosarcoma (genetics)</term>
<term>Hemangiosarcoma (pathology)</term>
<term>Hemangiosarcoma (therapy)</term>
<term>Humans</term>
<term>Male</term>
<term>Neoplasm Staging</term>
<term>Predictive Value of Tests</term>
<term>Risk Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Diagnostic différentiel</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hémangiosarcome ()</term>
<term>Hémangiosarcome (anatomopathologie)</term>
<term>Hémangiosarcome (diagnostic)</term>
<term>Hémangiosarcome (génétique)</term>
<term>Hémangiosarcome (étiologie)</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Stade de la tumeur</term>
<term>Valeur prédictive des tests</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Hémangiosarcome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hemangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Hémangiosarcome</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hemangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Hemangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Hémangiosarcome</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Hemangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hemangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hémangiosarcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Neoplasm Staging</term>
<term>Predictive Value of Tests</term>
<term>Risk Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Diagnostic différentiel</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hémangiosarcome</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Stade de la tumeur</term>
<term>Valeur prédictive des tests</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Angiosarcomas are rare soft-tissue sarcomas of endothelial cell origin that have a poor prognosis. They can arise anywhere in the body, most commonly presenting as cutaneous disease in elderly white men, involving the head and neck and particularly the scalp. They can be caused by therapeutic radiation or chronic lymphoedema and hence secondary breast angiosarcomas are an important subgroup. Recent work has sought to establish the molecular biology of angiosarcomas and identify specific targets for treatment. Interest is now focused on trials of vascular-targeted drugs, which are showing promise in the control of angiosarcomas. In this review we discuss angiosarcoma and its current management, with a focus on clinical trials investigating the treatment of advanced disease.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B66 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 003B66 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:20537949 |texte= Angiosarcoma. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:20537949" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |